Literature DB >> 11348908

Vitamin K policies and midwifery practice: questionnaire survey.

P Ansell1, E Roman, N T Fear, M J Renfrew.   

Abstract

OBJECTIVES: To investigate policies on neonatal vitamin K and their implementation.
DESIGN: Two phase postal survey.
SETTING: United Kingdom. PARTICIPANTS: A 10% random sample of midwives registered with the United Kingdom Central Council for nursing, midwifery, and health visiting. Of 3191 midwives in the sample, 2515 (79%) responded to phase one and 2294 (72%) completed questionnaires on their current jobs (November 1998 to May 1999). In phase two, 853 (62%) of 1383 eligible midwives gave details on 2179 of their earliest jobs (start dates before 1990).
RESULTS: All the midwives in clinical practice at the time of the survey (2271, 99%) reported that they were working in areas with official policies on neonatal vitamin K. Seven distinct policies were described: intramuscular vitamin K for all babies (1159, 51.0%); intramuscular vitamin K for babies at "high risk," oral for others (470, 20.7%); oral vitamin K for all babies (323, 14.2%); parental choice for all (124, 5.5%); parental choice for all except babies at high risk, (119, 5.2%); intramuscular vitamin K for babies at high risk only (33, 1.5%); oral vitamin K for babies at high risk only (17, 0.7%); and a disparate group of policies including intravenous vitamin K for some babies (26, 1.1%). Previous policies were (and some may still be) open to individual interpretation and were not always followed.
CONCLUSIONS: Hospital policy is not necessarily a good guide to individual practice. The primary purpose of clinical records is to document patient care, and recording practices reflect this. There is considerable variation in vitamin K policies and midwifery practice in the United Kingdom, and there is no clear consensus on which babies should receive vitamin K intramuscularly.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348908      PMCID: PMC31591          DOI: 10.1136/bmj.322.7295.1148

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  14 in total

1.  Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany.

Authors:  R von Kries; U Göbel; A Hachmeister; U Kaletsch; J Michaelis
Journal:  BMJ       Date:  1996-07-27

2.  Vitamin K prophylaxis against haemorrhagic disease of the newborn in the United Kingdom.

Authors:  J Handel; J H Tripp
Journal:  BMJ       Date:  1991-11-02

3.  Childhood leukaemia and intramuscular vitamin K: findings from a case-control study.

Authors:  P Ansell; D Bull; E Roman
Journal:  BMJ       Date:  1996-07-27

4.  Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study.

Authors:  L Parker; M Cole; A W Craft; E N Hey
Journal:  BMJ       Date:  1998-01-17

5.  Vitamin K regimens and incidence of childhood cancer in Denmark.

Authors:  J H Olsen; H Hertz; K Blinkenberg; H Verder
Journal:  BMJ       Date:  1994-04-02

6.  Neonatal vitamin K prophylaxis in the British Isles: current practice and trends.

Authors:  J S Barton; J H Tripp; A W McNinch
Journal:  BMJ       Date:  1995-03-11

7.  Oral vitamin K prophylaxis and frequency of late vitamin K deficiency bleeding.

Authors:  J S Barton; A W McNinch; J H Tripp
Journal:  Lancet       Date:  1994-05-07       Impact factor: 79.321

8.  The risk of childhood cancer after neonatal exposure to vitamin K.

Authors:  M A Klebanoff; J S Read; J L Mills; P H Shiono
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

9.  Administration of vitamin K to newborn infants and childhood cancer.

Authors:  H Ekelund; O Finnström; J Gunnarskog; B Källén; Y Larsson
Journal:  BMJ       Date:  1993-07-10

10.  Childhood cancer, intramuscular vitamin K, and pethidine given during labour.

Authors:  J Golding; R Greenwood; K Birmingham; M Mott
Journal:  BMJ       Date:  1992-08-08
View more
  7 in total

1.  Pharmacotherapy in the perinatal period--an exploratory study in midwifery.

Authors:  H Tobi; E Schirm; A M Verdegaal; L T de Jong-vd Berg
Journal:  Pharm World Sci       Date:  2001-12

2.  Ireland lacks consensus on neonatal vitamin K prophylaxis.

Authors:  R K Philip; R Gul; M Dunworth; N Keane
Journal:  BMJ       Date:  2001-11-03

3.  Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness.

Authors:  Alison Busfield; Andrew McNinch; John Tripp
Journal:  Arch Dis Child       Date:  2007-05-30       Impact factor: 3.791

Review 4.  Vitamin K--what, why, and when.

Authors:  E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

5.  Prevention of vitamin K deficiency bleeding with oral mixed micellar phylloquinone: results of a 6-year surveillance in Switzerland.

Authors:  Gregor Schubiger; Thomas M Berger; Roland Weber; Oskar Bänziger; Bernard Laubscher
Journal:  Eur J Pediatr       Date:  2003-10-24       Impact factor: 3.183

6.  Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies.

Authors:  E Roman; N T Fear; P Ansell; D Bull; G Draper; P McKinney; J Michaelis; S J Passmore; R von Kries
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

7.  Vitamin K and childhood cancer: a report from the United Kingdom Childhood Cancer Study.

Authors:  N T Fear; E Roman; P Ansell; J Simpson; N Day; O B Eden
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.